--2025/Q1-- / 13.466B--
--2024/Q4-- / 14.005B--
US Stock MarketDetailed Quotes
LLY Eli Lilly and Co
- 776.380
- -29.680-3.68%
Close Nov 6 16:00 ET
- 774.510
- -1.870-0.24%
Post 20:01 ET
737.03BMarket Cap83.93P/E (TTM)
820.730High767.610Low8.26MVolume817.330Open806.060Pre Close6.42BTurnover0.87%Turnover Ratio133.86P/E (Static)949.32MShares972.53052wk High51.76P/B736.23BFloat Cap558.92052wk Low5.03Dividend TTM948.29MShs Float972.530Historical High0.65%Div YieldTTM6.59%Amplitude5.287Historical Low776.893Avg Price1Lot Size
Eli Lilly and Co Key Stats
Eli Lilly and Co Q3 2024 Earnings Date
Overview | Q3 net profit of $0.97 billion, sales of major diet pills fell short of expectations, and full-year revenue guidance was lowered
Currency：USDOct 30, 2024
| Estimate (YoY) |
Actual (YoY) |
Vs Estimate (% Chg) |
|
| Revenue |
12.12B
|
11.44B
|
-679.50M
|
| Miss Est. |
+27.58%
|
+20.43%
|
-5.61%
|
| EPS |
1.54
|
1.07
|
-0.47
|
| Miss Est. |
+2677.80%
|
+1883.33%
|
-30.70%
|
Analyst Rating
Nov 6, 2024
Eli Lilly and Co Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Eli Lilly and Co Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
